BioCentury | Dec 22, 2016
Finance

Starting up stem cells

...need is for the manufacturing to work.” Brad Bolzon, Versant In 2015, Celyad S.A. and Medisun International Ltd....
...Academia Japan Inc., Kyoto, Japan Juno Therapeutics Inc. (NASDAQ:JUNO), Seattle, Wash. Kyoto University, Kyoto, Japan Medisun International Ltd....
BioCentury | Apr 4, 2016
Finance

2Q milestones

...Inc. (NASDAQ:CLVS) Rociletinib NSCLC FDA panel; PDUFA date 4/12/16; 6/28/16 Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD) / Medisun International Ltd....
BioCentury | Jan 11, 2016
Finance

Sowing season

...rindopepimut EGFRvIII-positive newly diagnosed glioblastoma Final Ph III data YE16 Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD) / Medisun International Ltd....
BioCentury | Sep 28, 2015
Company News

Celyad, Medisun International deal

...companies did not respond to inquiries (see BioCentury, April 13). Celyad S.A. (Euronext:CYAD;NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Medisun International Ltd....
BioCentury | Jul 14, 2014
Financial News

Cardio3 BioSciences S.A completes private placement

...Raised: EUR12.5 million ($17.1 million) Shares: 284,090 Price: EUR44 Shares after offering: 7 million Investor: Medisun International Ltd....
BioCentury | Jul 14, 2014
Finance

Highlights of weekly biotech stock moves

...at €44 in the second tranche of a €25 million ($34 million) private placement to Medisun International Ltd....
BioCentury | Jul 2, 2014
Financial News

Cardio3 BioSciences raises EUR 12.5 million

...44 in the second tranche of a EUR 25 million ($34 million) private placement to Medisun International Ltd....
BioCentury | Jun 23, 2014
Company News

Cardio3 BioSciences S.A, Medisun International deal

...patient’s heart via Cardio3’s C-Cath intra-myocardial delivery catheter. Cardio3 BioSciences S.A . (Euronext:CARD), Mont-Saint-Guibert, Belgium Medisun International Ltd....
Items per page:
1 - 8 of 8
BioCentury | Dec 22, 2016
Finance

Starting up stem cells

...need is for the manufacturing to work.” Brad Bolzon, Versant In 2015, Celyad S.A. and Medisun International Ltd....
...Academia Japan Inc., Kyoto, Japan Juno Therapeutics Inc. (NASDAQ:JUNO), Seattle, Wash. Kyoto University, Kyoto, Japan Medisun International Ltd....
BioCentury | Apr 4, 2016
Finance

2Q milestones

...Inc. (NASDAQ:CLVS) Rociletinib NSCLC FDA panel; PDUFA date 4/12/16; 6/28/16 Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD) / Medisun International Ltd....
BioCentury | Jan 11, 2016
Finance

Sowing season

...rindopepimut EGFRvIII-positive newly diagnosed glioblastoma Final Ph III data YE16 Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD) / Medisun International Ltd....
BioCentury | Sep 28, 2015
Company News

Celyad, Medisun International deal

...companies did not respond to inquiries (see BioCentury, April 13). Celyad S.A. (Euronext:CYAD;NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Medisun International Ltd....
BioCentury | Jul 14, 2014
Financial News

Cardio3 BioSciences S.A completes private placement

...Raised: EUR12.5 million ($17.1 million) Shares: 284,090 Price: EUR44 Shares after offering: 7 million Investor: Medisun International Ltd....
BioCentury | Jul 14, 2014
Finance

Highlights of weekly biotech stock moves

...at €44 in the second tranche of a €25 million ($34 million) private placement to Medisun International Ltd....
BioCentury | Jul 2, 2014
Financial News

Cardio3 BioSciences raises EUR 12.5 million

...44 in the second tranche of a EUR 25 million ($34 million) private placement to Medisun International Ltd....
BioCentury | Jun 23, 2014
Company News

Cardio3 BioSciences S.A, Medisun International deal

...patient’s heart via Cardio3’s C-Cath intra-myocardial delivery catheter. Cardio3 BioSciences S.A . (Euronext:CARD), Mont-Saint-Guibert, Belgium Medisun International Ltd....
Items per page:
1 - 8 of 8